{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2023,9,25]],"date-time":"2023-09-25T08:57:19Z","timestamp":1695632239035},"reference-count":0,"publisher":"Cleveland Clinic Journal of Medicine","issue":"Suppl_1","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Cleveland Clinic Journal of Medicine"],"published-print":{"date-parts":[[2002,4,1]]},"DOI":"10.3949\/ccjm.69.suppl_1.si59","type":"journal-article","created":{"date-parts":[[2009,4,3]],"date-time":"2009-04-03T23:51:01Z","timestamp":1238802661000},"page":"SI59-SI59","source":"Crossref","is-referenced-by-count":4,"title":["Developing an economic rationale for the use of selective COX-2 inhibitors for patients at risk for NSAID gastropathy."],"prefix":"10.3949","volume":"69","author":[{"given":"A M.","family":"Fendrick","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"2443","container-title":["Cleveland Clinic Journal of Medicine"],"original-title":[],"language":"en","deposited":{"date-parts":[[2011,3,24]],"date-time":"2011-03-24T03:45:44Z","timestamp":1300938344000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.ccjm.org\/cgi\/doi\/10.3949\/ccjm.69.Suppl_1.SI59"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2002,4,1]]},"references-count":0,"journal-issue":{"issue":"Suppl_1","published-print":{"date-parts":[[2002,4,1]]}},"URL":"https:\/\/doi.org\/10.3949\/ccjm.69.suppl_1.si59","relation":{},"ISSN":["0891-1150","1939-2869"],"issn-type":[{"value":"0891-1150","type":"print"},{"value":"1939-2869","type":"electronic"}],"subject":[],"published":{"date-parts":[[2002,4,1]]}}}